BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

160 related articles for article (PubMed ID: 2488095)

  • 1. Deleterious effects of intravenous verapamil in Wolff-Parkinson-White patients and atrial fibrillation.
    Strasberg B; Sagie A; Rechavia E; Katz A; Ovsyscher IA; Sclarovsky S; Agmon J
    Cardiovasc Drugs Ther; 1989 Jan; 2(6):801-6. PubMed ID: 2488095
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Precipitation of cardiac arrest by verapamil in patients with Wolff-Parkinson-White syndrome.
    McGovern B; Garan H; Ruskin JN
    Ann Intern Med; 1986 Jun; 104(6):791-4. PubMed ID: 3706931
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Acceleration of the ventricular response during atrial fibrillation in the Wolff-Parkinson-White syndrome after verapamil.
    Gulamhusein S; Ko P; Carruthers SG; Klein GJ
    Circulation; 1982 Feb; 65(2):348-54. PubMed ID: 7053894
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Wolff-Parkinson-White syndrome and verapamil: apropos of a case of ventricular fibrillation].
    Michel B; Goy JJ; Kappenberger L
    Schweiz Med Wochenschr; 1989 May; 119(19):630-4. PubMed ID: 2740877
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Fatal ventricular fibrillation following verapamil in Wolff-Parkinson-White syndrome with atrial fibrillation.
    Jacob AS; Nielsen DH; Gianelly RE
    Ann Emerg Med; 1985 Feb; 14(2):159-60. PubMed ID: 3970402
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Augmented ventricular rate following verapamil treatment for atrial fibrillation with Wolff-Parkinson-White syndrome.
    Rowland TW
    Pediatrics; 1983 Aug; 72(2):245-6. PubMed ID: 6866612
    [No Abstract]   [Full Text] [Related]  

  • 7. Effect of flestolol on ventricular rate during atrial fibrillation in Wolff-Parkinson-White syndrome.
    Swerdlow CD; Peterson J; Liem LB
    Am J Cardiol; 1988 Jul; 62(1):78-82. PubMed ID: 2898208
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Atrial fibrillation with wide QRS tachycardia and undiagnosed Wolff-Parkinson-White syndrome: diagnostic and therapeutic dilemmas in a pediatric patient.
    Panduranga P; Al-Farqani A; Al-Rawahi N
    Pediatr Emerg Care; 2012 Nov; 28(11):1227-9. PubMed ID: 23128652
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effects of intravenous verapamil on cardiac arrhythmias and on the electrocardiogram.
    Heng MK; Singh BN; Roche AH; Norris RM; Mercer CJ
    Am Heart J; 1975 Oct; 90(4):487-98. PubMed ID: 1163442
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Effect of isoptin in auricular fibrillation in a patient with Wolff-Parkinson-White syndrome].
    Golitsyn SP; Sokolov SF; Mazur NA
    Kardiologiia; 1979 Jul; 19(7):102-5. PubMed ID: 470312
    [No Abstract]   [Full Text] [Related]  

  • 11. Clinical presentation and treatment of atrial fibrillation in Wolff-Parkinson-White syndrome.
    Thanavaro JL; Thanavaro S
    Heart Lung; 2010; 39(2):131-6. PubMed ID: 20207273
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Disopyramide in patients with the Wolff-Parkinson-White syndrome and atrial fibrillation.
    Bennett DH
    Chest; 1978 Dec; 74(6):624-8. PubMed ID: 738119
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Atrial fibrillation in Wolff-Parkinson-White syndrome: reversal of isoproterenol effects by sotalol.
    Madrid AH; Moro C; Maŕin Huerta EM; Novo L; Mestre JL
    Pacing Clin Electrophysiol; 1992 Nov; 15(11 Pt 2):2111-5. PubMed ID: 1279609
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Comparison of the ventricular response during atrial fibrillation in patients with enhanced atrioventricular node conduction and Wolff-Parkinson-White syndrome.
    Milstein S; Klein GJ; Rattes MF; Sharma AD; Yee R
    J Am Coll Cardiol; 1987 Dec; 10(6):1244-8. PubMed ID: 3680792
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [2 episodes of ventricular fibrillation in a patient with mild paroxysms of Wolff-Parkinson-White syndrome].
    Walczak F; Nyznyk M; Biederman A; Jedynak Z; Bujnowska E
    Kardiol Pol; 1992 Nov; 37(11):311-3. PubMed ID: 1287293
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Atrial fibrillation in the Wolff-Parkinson-White syndrome: effects of verapamil and procainamide.
    Laufer N; Crevey B
    Ariz Med; 1985 Mar; 42(3):150-3. PubMed ID: 3994532
    [No Abstract]   [Full Text] [Related]  

  • 17. Paroxysmal atrial flutter and fibrillation associated with preexcitation syndrome: treatment with ajmaline.
    Sclarovsky S; Kracoff OH; Strasberg B; Lewin RF; Agmon J
    Am J Cardiol; 1981 Nov; 48(5):929-33. PubMed ID: 7304440
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Ventricular fibrillation in Wolff-Parkinson-White syndrome, type A.
    Papa LA; Saia JA; Chung EK
    Heart Lung; 1978; 7(6):1015-9. PubMed ID: 251167
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Misuse of verapamil in pre-excited atrial fibrillation.
    Garratt C; Antoniou A; Ward D; Camm AJ
    Lancet; 1989 Feb; 1(8634):367-9. PubMed ID: 2563516
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effects of verapamil on the electrophysiologic properties of the accessory pathway in patients with the Wolff-Parkinson-White syndrome.
    Harper RW; Whitford E; Middlebrook K; Federman J; Anderson S; Pitt A
    Am J Cardiol; 1982 Dec; 50(6):1323-30. PubMed ID: 7148709
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.